Drug
Magnevist
Magnevist is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Phase Distribution
Ph phase_4
1
20%
Ph phase_3
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
4
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Other(1)
Detailed Status
Completed4
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 33 (75.0%)
Phase 41 (25.0%)
Trials by Status
unknown120%
completed480%
Recent Activity
0 active trials
Showing 5 of 5
completed
Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography
NCT03910114
unknownphase_4
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
NCT01956409
completedphase_3
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
NCT00395460
completedphase_3
Multihance Versus Magnevist in Breast MRI
NCT00486473
completedphase_3
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
NCT00408083
Clinical Trials (5)
Showing 5 of 5 trials
NCT03910114
Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography
NCT01956409Phase 4
Proton MR Spectroscopy and 18F-Fluorocholine PET for Breast Cancer Diagnosis
NCT00395460Phase 3
Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients
NCT00486473Phase 3
Multihance Versus Magnevist in Breast MRI
NCT00408083Phase 3
Crossover Study With MultiHance vs a Comparator for Peripheral MRA
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5